C32.0 ICD-10-CM Code: Malignant neoplasm of glottis
Compare with another codeCheck this code on a claim
Billing Status: YES. This is a valid, specific, and billable ICD-10-CM reference.
Coding at a Glance
- Tabular directives
- 4 inclusion terms · 1 Excludes1 · 8 use-additional codes
- Risk adjustment
- CMS-HCC V28: 1 category · CMS-HCC V22 category 11
Billable · FY2027A valid, specific ICD-10-CM code, reportable for dates of service in FY2027.
What you need to know
Source: CMS/NCHS Official ICD-10-CM tabular notes, quoted. From the CMS/NCHS tabular list for the release in force. A note the category or block publishes applies to this code too; the Instructions section marks which is which.
- Use additional codeReport with this code when documented
- Excludes1Never report with this code
- mesothelioma (C45.-)
- IncludesWhat this code covers
- malignant neoplasm of middle ear
- Malignant neoplasm of intrinsic larynx
- Malignant neoplasm of laryngeal commissure (anterior)(posterior)
- Malignant neoplasm of vocal cord (true) NOS
Most relevant related codes MedCoder-derived
Read off the official notes above and this code’s own position in the tabular list. Which to report is a documentation question; Compare shows the two side by side.
Inpatient Payment Groups (MS-DRG)
Potential MS-DRG participation — not a DRG assignment.
MS-DRGs this diagnosis helps define, as principal or secondary, per the CMS ICD-10-CM/PCS MS-DRG Definitions Manual v44, Appendix B.
- MS-DRG 011 — TRACHEOSTOMY FOR FACE, MOUTH AND NECK DIAGNOSES OR LARYNGECTOMY WITH MCC (MDC PRE)
- MS-DRG 012 — TRACHEOSTOMY FOR FACE, MOUTH AND NECK DIAGNOSES OR LARYNGECTOMY WITH CC (MDC PRE)
- MS-DRG 013 — TRACHEOSTOMY FOR FACE, MOUTH AND NECK DIAGNOSES OR LARYNGECTOMY WITHOUT CC/MCC (MDC PRE)
- MS-DRG 146 — EAR, NOSE, MOUTH AND THROAT MALIGNANCY WITH MCC (MDC 03)
- MS-DRG 147 — EAR, NOSE, MOUTH AND THROAT MALIGNANCY WITH CC (MDC 03)
- MS-DRG 148 — EAR, NOSE, MOUTH AND THROAT MALIGNANCY WITHOUT CC/MCC (MDC 03)
A diagnosis appearing in a group's logic does not by itself determine the DRG assigned to a stay; the grouper uses the full claim.
Risk Adjustment (CMS-HCC)
Payment categories this diagnosis maps to under CMS-HCC V28, payment year 2026.
- HCC 21 — Lymphoma and Other Cancers (supersedes HCC 22, HCC 23)
Other models: CMS-HCC V22 HCC 11
Risk scores depend on the enrollee's full accepted diagnosis set and segment; a category mapping alone does not determine payment.
Coding instructions
Official Tabular Instructional Notes: the inclusion, exclusion and sequencing notes published for C32.0 in the official ICD-10-CM tabular list, quoted as published.
Source: CMS/CDC — ICD-10-CM Tabular ListRelease: FY2027Effective: October 1, 2026
Trace:FY2027 changesChange historyRelease, file and checksum
Notes without a marker are published on C32.0 itself; “inherited from” names the category or block whose note applies here.
Includes
Conditions the official ICD-10-CM tabular list includes under this code.
- malignant neoplasm of middle ear
Source: inherited from C30-C39
Inclusion Terms
Alternative terms the tabular list files under this code.
- Malignant neoplasm of intrinsic larynx
- Malignant neoplasm of laryngeal commissure (anterior)(posterior)
- Malignant neoplasm of vocal cord (true) NOS
Excludes1 — Not Coded Here
Conditions generally not reported together with this code (Excludes1) -- an error unless the two conditions are documented as unrelated to each other (ICD-10-CM Official Guidelines, Section I.A.12.a).
- mesothelioma (C45.-) Compare C32.0 vs C45 →
Source: inherited from C30-C39
Use Additional Code
Supplementary codes the tabular list directs you to add.
- Use additional code to identify:
- alcohol abuse and dependence (F10.-)
- exposure to environmental tobacco smoke (Z77.22)
- exposure to tobacco smoke in the perinatal period (P96.81)
- history of tobacco dependence (Z87.891)
- occupational exposure to environmental tobacco smoke (Z57.31)
- tobacco dependence (F17.-)
- tobacco use (Z72.0)
Source: inherited from C32
Coder workflow for C32.0
MedCoder structured workflow — derived from this code’s own official record
Before you code C32.0
- Confirm the documented site and behavior (this code’s block classifies malignant neoplasms), whether the site is primary or secondary, and whether the malignancy is current or a personal history: a previously excised malignancy with no further treatment and no evidence of disease is history, not current disease. Verify the site against the Table of Neoplasms. Neoplasm chapter guidelines (Guidelines I.C.2.a, I.C.2.d, I.C.2.m).
See the Table of Neoplasms entries · Guide: Active cancer vs history of cancer →
- Check the Excludes1 note: if the documentation supports a condition named there, do not simply proceed with C32.0. Excludes1 conditions are not reported together with this code unless the record shows they are unrelated (Guidelines I.A.12.a).
Choose the right path
- Does the documentation support a condition named in C32.0’s Excludes1 note?
Yes → Do not simply proceed: review the excluded code. Both are reported only when the record shows the two conditions are unrelated.
No → Continue.ReviewC45
Consider C32.0. Then work the Use Additional Code note, and confirm the code is valid for the date of service in the Verify section.
Documentation check
- The provider’s diagnostic statement
- Codes are assigned from the provider’s documented diagnosis, not from clinical criteria, test values or a medication list (Guidelines I.A.19).
- Anatomical site
- At the most specific level the record states; a site the classification separates cannot be assumed from a procedure or a measurement.
- The conditions the Use Additional Code note names
- Reported with this code when documented; a conditional instruction (“if applicable”, “if known”) applies only when the record supports it.
- Behavior and current-versus-history status
- Malignant, in situ, benign or uncertain; primary or secondary; current disease or personal history (Guidelines I.C.2.m).
Official instructions as workflow
Excludes1 — check before selecting C32.0(1 note)
Coding workflow: If the documentation supports a condition named in this note, do not simply proceed with C32.0: the two are not reported together. The one exception is when the record shows the two conditions are unrelated to each other.
CompareC45
See the official tabular notes · Guidelines I.A.12.a
Use Additional Code — after identifying C32.0(8 notes)
Coding workflow: Check whether the documentation supports the additional code(s) the note names, and report them with C32.0 when it does. Where the instruction is conditional (“if applicable”, “if known”), it applies only when the record documents the condition.
ReviewF10, Z77.22, P96.81, Z87.891, Z57.31, F17
See the official tabular notes · Guidelines I.A.13
Coding decision scenarios
Pattern scenarios for this code’s structure — decision rules, not clinical cases
Documentation: Both the condition C32.0 describes and a condition named in its Excludes1 note are documented for the same encounter.
Coding question: Can both codes be reported?
Path: Review the Excludes1 note and the excluded code, and look for a provider statement on whether the two conditions are related.
Reason: Excludes1 means the two are not coded together; the exception is when the record shows the conditions are unrelated to each other (Guidelines I.A.12.a).
ReviewC45
Documentation: A condition the Use Additional Code note names is documented.
Coding question: Is a second code reported with C32.0?
Path: Review the Use Additional Code note and the code it names.
Reason: The additional code is reported when the record documents the condition; a conditional instruction applies only when its condition is met (Guidelines I.A.13).
Every row is derived from this code’s own record — its title, tabular notes, 7th-character family and same-category siblings — with fixed MedCoder wording; nothing is inferred about a patient. The official notes and guideline text are in the sections each row links to, and they control.
Coding context
Guidelines, coding notes, decision aids, relationships (with MS-DRG and CCSR classification), hierarchy, HCC, coverage and the context map: what a coder reaches for after the core. Each section names whether it is official source data, a MedCoder-derived relationship or MedCoder editorial.
Code Overview
MedCoder summary Summary composed by MedCoder from this code's official ICD-10-CM record. The tabular instructional notes themselves appear verbatim below.
Verify Before Coding
- No Medicare Code Editor or MS-DRG Definitions Manual restrictions apply to this code.
From the code registry, the Medicare Code Editor, and the MS-DRG Definitions Manual. Check it against a full claim in Claim Check.
Relationships & Classification
MedCoder-derived relationships — computed from published CMS and AHRQ datasets
Other codes that name C32.0 or its code family, from the CMS Table of Neoplasms and the CMS Table of Neoplasms (site match derived from the code title).
Referenced by 5 Same-site neoplasm codes: C78.31 — Secondary malignant neoplasm of larynxCompare C32.0 vs C78.31 →, D02.0 — Carcinoma in situ of larynxCompare C32.0 vs D02.0 →, D14.1 — Benign neoplasm of larynxCompare C32.0 vs D14.1 →, D38.0 — Neoplasm of uncertain behavior of larynxCompare C32.0 vs D38.0 →, D49.1 — Neoplasm of unspecified behavior of respiratory systemCompare C32.0 vs D49.1 →.
These codes represent related neoplasm behaviors affecting the same anatomic site.
Referenced by 1 Screening & history code: Z85.21 — Personal history of malignant neoplasm of larynxCompare C32.0 vs Z85.21 →.
These codes represent screening tests and history codes that refer to this active disease condition.
MS-DRG Grouper Relationships (FY2027)
Potential MS-DRG participation — not a DRG assignment.
FY2027 MS-DRG: not on the CMS CC/MCC list — as a secondary diagnosis this code does not change MS-DRG severity for that release.
Named in the grouper logic of 6 MS-DRGs: DRG 011 (MDC PRE), DRG 012 (MDC PRE), DRG 013 (MDC PRE), DRG 146 (MDC 03), DRG 147 (MDC 03), DRG 148 (MDC 03).
From the CMS MS-DRG Definitions Manual (Appendices B and C). Actual DRG assignment depends on the complete claim.
Clinical classification (AHRQ CCSR):NEO008 — Head and neck cancers - laryngeal (default).
Clinical Classifications Software Refined (CCSR) for ICD-10-CM Diagnoses. Healthcare Cost and Utilization Project (HCUP), Agency for Healthcare Research and Quality.
Related Codes
Same CMS-HCC risk category (V28)
CMS maps these diagnoses to the same Hierarchical Condition Category (Lymphoma and Other Cancers) for risk-adjusted payment.
C14.2 — Malignant neoplasm of Waldeyer's ring, C14.8 — Malignant neoplasm of overlapping sites of lip, oral cavity and pharynx, C30.0 — Malignant neoplasm of nasal cavity, C30.1 — Malignant neoplasm of middle ear, C31.0 — Malignant neoplasm of maxillary sinus, C31.1 — Malignant neoplasm of ethmoidal sinus, C31.2 — Malignant neoplasm of frontal sinus, C31.3 — Malignant neoplasm of sphenoid sinus, C31.8 — Malignant neoplasm of overlapping sites of accessory sinuses, C31.9 — Malignant neoplasm of accessory sinus, unspecified, C32.1 — Malignant neoplasm of supraglottis, C32.2 — Malignant neoplasm of subglottis, C32.3 — Malignant neoplasm of laryngeal cartilage, C32.8 — Malignant neoplasm of overlapping sites of larynx, C32.9 — Malignant neoplasm of larynx, unspecified, C37 — Malignant neoplasm of thymus, C38.1 — Malignant neoplasm of anterior mediastinum, C38.2 — Malignant neoplasm of posterior mediastinum, C38.3 — Malignant neoplasm of mediastinum, part unspecified, C38.8 — Malignant neoplasm of overlapping sites of heart, mediastinum and pleura, +442 more
Related risk categories
These categories interact through CMS's HCC hierarchy — one can suppress the other's risk-adjustment weight when both are present on a claim.
Cancer Metastatic to Lung, Liver, Brain, and Other Organs; Acute Myeloid Leukemia Except Promyelocytic, Cancer Metastatic to Bone, Other and Unspecified Metastatic Cancer; Acute Leukemia Except Myeloid, Myelodysplastic Syndromes, Multiple Myeloma, and Other Cancers, Lung and Other Severe Cancers, Bladder, Colorectal, and Other Cancers, Prostate, Breast, and Other Cancers and Tumors
Same clinical category (CCSR)
AHRQ's Clinical Classifications Software groups these diagnoses under the same clinical category (Head and neck cancers - laryngeal).
C32.1 — Malignant neoplasm of supraglottis, C32.2 — Malignant neoplasm of subglottis, C32.3 — Malignant neoplasm of laryngeal cartilage, C32.8 — Malignant neoplasm of overlapping sites of larynx, C32.9 — Malignant neoplasm of larynx, unspecified, D02.0 — Carcinoma in situ of larynx
Lab tests where this diagnosis supports Medicare coverage (NCD)
Medicare's National Coverage Determination (NCD) program lists this diagnosis as medical justification for these lab tests.
Contextual Map
Every relationship of C32.0 in one view: hierarchy, official tabular instructions in both directions, clinical classification, risk adjustment, MS-DRG participation, index terms and change history — each edge carrying the CMS source it derives from.
Hierarchy
- C00-D49 — Chapter 2: Neoplasms (C00-D49) (C00-D49)[Hierarchy]— CMS ICD-10-CM tabular structure · icd10cm-fy2027
- C00-C75 — Malignant neoplasms, stated or presumed to be primary (of specified sites), and certain specified histologies, except neuroendocrine, and of lymphoid, hematopoietic and related tissue[Hierarchy]— CMS ICD-10-CM tabular structure · icd10cm-fy2027
Same site
- C78.31 — Secondary malignant neoplasm of larynx[Same site]: “Same site — secondary malignancy (commissure)”— CMS Table of Neoplasms · icd10cm-fy2027
- D02.0 — Carcinoma in situ of larynx[Same site]: “Same site — carcinoma in situ (commissure)”— CMS Table of Neoplasms · icd10cm-fy2027
- D14.1 — Benign neoplasm of larynx[Same site]: “Same site — benign neoplasm (commissure)”— CMS Table of Neoplasms · icd10cm-fy2027
- D38.0 — Neoplasm of uncertain behavior of larynx[Same site]: “Same site — uncertain behavior (commissure)”— CMS Table of Neoplasms · icd10cm-fy2027
- D49.1 — Neoplasm of unspecified behavior of respiratory system[Same site]: “Same site — unspecified behavior (commissure)”— CMS Table of Neoplasms · icd10cm-fy2027
Referenced by Same-site neoplasm codes
- C78.31 — Secondary malignant neoplasm of larynx[Same site]: “Same site — primary malignancy (commissure)”— CMS Table of Neoplasms · icd10cm-fy2027
- D02.0 — Carcinoma in situ of larynx[Same site]: “Same site — primary malignancy (commissure)”— CMS Table of Neoplasms · icd10cm-fy2027
- D14.1 — Benign neoplasm of larynx[Same site]: “Same site — primary malignancy (commissure)”— CMS Table of Neoplasms · icd10cm-fy2027
- D38.0 — Neoplasm of uncertain behavior of larynx[Same site]: “Same site — primary malignancy (commissure)”— CMS Table of Neoplasms · icd10cm-fy2027
- D49.1 — Neoplasm of unspecified behavior of respiratory system[Same site]: “Same site — primary malignancy (commissure)”— CMS Table of Neoplasms · icd10cm-fy2027
Referenced by Screening & history codes MedCoder-derived
- Z85.21 — Personal history of malignant neoplasm of larynx[Lifecycle]: “Active disease for this site (larynx)”— CMS Table of Neoplasms (site match derived from the code title) · icd10cm-fy2027
Clinical classification (CCSR)
- NEO008 — Head and neck cancers - laryngeal[CCSR]— AHRQ CCSR for ICD-10-CM Diagnoses (HCUP)
Risk adjustment (CMS-HCC)
- HCC 21 — Lymphoma and Other Cancers [CMS-HCC]: “Lymphoma and Other Cancers — supersedes HCC 22 (Bladder, Colorectal, and Other Cancers), HCC 23 (Prostate, Breast, and Other Cancers and Tumors)”— CMS-HCC V28 · 2026
MS-DRG Grouper
- DRG 011 — TRACHEOSTOMY FOR FACE, MOUTH AND NECK DIAGNOSES OR LARYNGECTOMY WITH MCC[MS-DRG]: “TRACHEOSTOMY FOR FACE, MOUTH AND NECK DIAGNOSES OR LARYNGECTOMY WITH MCC (MDC PRE)”— CMS MS-DRG Definitions Manual (Appendix B) · FY2027
- DRG 012 — TRACHEOSTOMY FOR FACE, MOUTH AND NECK DIAGNOSES OR LARYNGECTOMY WITH CC[MS-DRG]: “TRACHEOSTOMY FOR FACE, MOUTH AND NECK DIAGNOSES OR LARYNGECTOMY WITH CC (MDC PRE)”— CMS MS-DRG Definitions Manual (Appendix B) · FY2027
- DRG 013 — TRACHEOSTOMY FOR FACE, MOUTH AND NECK DIAGNOSES OR LARYNGECTOMY WITHOUT CC/MCC[MS-DRG]: “TRACHEOSTOMY FOR FACE, MOUTH AND NECK DIAGNOSES OR LARYNGECTOMY WITHOUT CC/MCC (MDC PRE)”— CMS MS-DRG Definitions Manual (Appendix B) · FY2027
- DRG 146 — EAR, NOSE, MOUTH AND THROAT MALIGNANCY WITH MCC[MS-DRG]: “EAR, NOSE, MOUTH AND THROAT MALIGNANCY WITH MCC (MDC 03)”— CMS MS-DRG Definitions Manual (Appendix B) · FY2027
- DRG 147 — EAR, NOSE, MOUTH AND THROAT MALIGNANCY WITH CC[MS-DRG]: “EAR, NOSE, MOUTH AND THROAT MALIGNANCY WITH CC (MDC 03)”— CMS MS-DRG Definitions Manual (Appendix B) · FY2027
- DRG 148 — EAR, NOSE, MOUTH AND THROAT MALIGNANCY WITHOUT CC/MCC[MS-DRG]: “EAR, NOSE, MOUTH AND THROAT MALIGNANCY WITHOUT CC/MCC (MDC 03)”— CMS MS-DRG Definitions Manual (Appendix B) · FY2027
MDC crossing
- Pre-MDC[MDC crossing]: “Pre-MDC — the grouper's crossing between diagnoses and procedures: a principal diagnosis sets the MDC, and same-MDC procedures move the stay to its surgical DRGs. 175 same-MDC procedures group here; browse them on the MDC page.”— CMS MS-DRG Definitions Manual · FY2027
- MDC 03 — Diseases and Disorders of the Ear, Nose, Mouth and Throat[MDC crossing]: “Diseases and Disorders of the Ear, Nose, Mouth and Throat — the grouper's crossing between diagnoses and procedures: a principal diagnosis sets the MDC, and same-MDC procedures move the stay to its surgical DRGs. 5,151 same-MDC procedures group here; browse them on the MDC page.”— CMS MS-DRG Definitions Manual · FY2027
Neoplasm sites
- Neoplasm, neoplastic, commissure, laryngeal — Neoplasm, neoplastic, commissure, laryngeal — Malignant, Primary [Neoplasm table]: “Neoplasm, neoplastic, commissure, laryngeal (Malignant, Primary)”— CMS Table of Neoplasms · icd10cm-fy2027
- Neoplasm, neoplastic, cord (true) (vocal) — Neoplasm, neoplastic, cord (true) (vocal) — Malignant, Primary [Neoplasm table]: “Neoplasm, neoplastic, cord (true) (vocal) (Malignant, Primary)”— CMS Table of Neoplasms · icd10cm-fy2027
- Neoplasm, neoplastic, glottis — Neoplasm, neoplastic, glottis — Malignant, Primary [Neoplasm table]: “Neoplasm, neoplastic, glottis (Malignant, Primary)”— CMS Table of Neoplasms · icd10cm-fy2027
- Neoplasm, neoplastic, larynx, laryngeal NEC, commissure (anterior) (posterior) — Neoplasm, neoplastic, larynx, laryngeal NEC, commissure (anterior) (posterior) — Malignant, Primary [Neoplasm table]: “Neoplasm, neoplastic, larynx, laryngeal NEC, commissure (anterior) (posterior) (Malignant, Primary)”— CMS Table of Neoplasms · icd10cm-fy2027
- Neoplasm, neoplastic, larynx, laryngeal NEC, intrinsic — Neoplasm, neoplastic, larynx, laryngeal NEC, intrinsic — Malignant, Primary [Neoplasm table]: “Neoplasm, neoplastic, larynx, laryngeal NEC, intrinsic (Malignant, Primary)”— CMS Table of Neoplasms · icd10cm-fy2027
- Neoplasm, neoplastic, vocal cords (true) — Neoplasm, neoplastic, vocal cords (true) — Malignant, Primary [Neoplasm table]: “Neoplasm, neoplastic, vocal cords (true) (Malignant, Primary)”— CMS Table of Neoplasms · icd10cm-fy2027
Nearest codes
- C32 — Malignant neoplasm of larynx[Sibling]— CMS ICD-10-CM tabular structure · icd10cm-fy2027
- C32.1 — Malignant neoplasm of supraglottis[Sibling]— CMS ICD-10-CM tabular structure · icd10cm-fy2027
- C32.2 — Malignant neoplasm of subglottis[Sibling]— CMS ICD-10-CM tabular structure · icd10cm-fy2027
- C32.3 — Malignant neoplasm of laryngeal cartilage[Sibling]— CMS ICD-10-CM tabular structure · icd10cm-fy2027
- C32.8 — Malignant neoplasm of overlapping sites of larynx[Sibling]— CMS ICD-10-CM tabular structure · icd10cm-fy2027
- C32.9 — Malignant neoplasm of larynx, unspecified[Sibling]— CMS ICD-10-CM tabular structure · icd10cm-fy2027
Change history
- FY2016 — In the code set at ICD-10-CM adoption [Change history]— CMS release files (code change ledger) · icd10cm-fy2016
Reference
Index terms and tables, published questions and FAQ, every source behind this page with its release and checksum, the date-of-service check and the complete change history.
Neoplasm Table Sites (6)
Official source data — entries quoted as published, in the Index’s own lookup phrasing
Anatomical sites from the official ICD-10-CM Table of Neoplasms that map to this code, with the matching behavior column.
- Neoplasm, neoplastic, commissure, laryngeal — Malignant, Primary
- Neoplasm, neoplastic, cord (true) (vocal) — Malignant, Primary
- Neoplasm, neoplastic, glottis — Malignant, Primary
- Neoplasm, neoplastic, larynx, laryngeal NEC, commissure (anterior) (posterior) — Malignant, Primary
- Neoplasm, neoplastic, larynx, laryngeal NEC, intrinsic — Malignant, Primary
- Neoplasm, neoplastic, vocal cords (true) — Malignant, Primary
Sources for this page
Codes, titles, notes, index terms and mappings on this page are transcribed from the datasets below. Relationships MedCoder computed and text MedCoder wrote are labelled where they appear.
- Code, title, tabular notes and index terms Official source data
- CMS/CDC ICD-10-CM FY2027 tabular list, index and tables, effective October 1, 2026 Release, file and checksum · Publisher’s page
- Claim edits Official source data
- CMS Definitions of Medicare Code Edits — v44.0 (October 2026) Release, file and checksum · Publisher’s page
- Inpatient payment groups Official source data
- CMS MS-DRG Definitions Manual (incl. Appendix B diagnosis index, Appendix C CC/MCC list, Appendix E procedure index) and IPPS Final Rule tables — v44 Release, file and checksum · Publisher’s page
- Risk adjustment Official source data
- 2026 Mid-Year Final ICD-10 Mappings + Model Software (cms.gov/files/zip/2026-midyear-final-icd-10-mappings.zip, 2026-midyear-final-model-software.zip) — CMS-HCC V28, PY2026 mid-year final release Release, file and checksum · Publisher’s page
- Change history and date-of-service validity Official source data
- CMS ICD-10-CM release addenda, ingested release by release into the change ledger Release, file and checksum · Publisher’s page
- Comparisons, relationships and the contextual map MedCoder-derived relationship
- Computed by MedCoder from the tabular notes and tables above; every derived relationship is marked as derived where it appears
- Summary and FAQ answers MedCoder editorial explanation
- Written by MedCoder to explain the sources above: drafted with AI assistance, checked by a person against the release files, and labelled as MedCoder text where it appears. Not official text.
Current data releases:ICD-10-CM FY2027 · ICD-10-PCS FY2027 · HCPCS October 2026 · MS-DRG v44 · Medicare Code Editor v44.0 · NCCI PTP Q4 2026 · MUE Q4 2026 · NCD code lists 2026-01 · LCD export September 20, 2026 · All releases and sources
Labels on this page: Official source data · MedCoder-derived relationship · MedCoder editorial explanation. How to read the labels · All data sources and release dates · CMS coding rules
Cite this page
Reference this page in a research guide, syllabus or article. The release is included because code content changes each year.
MedCoder.ai. "C32.0 — Malignant neoplasm of glottis." ICD-10-CM FY2027. https://medcoder.ai/icd10/code/c32.0-malignant-neoplasm-of-glottis
Change history
- FY2016 — October 1, 2015In the code set at ICD-10-CM adoptionMalignant neoplasm of glottis
No changes since FY2016 — additions, deletions, description changes and billable-status changes are tracked through FY2027, and none are recorded for this code. Note changes are tracked from FY2027 only.
Nearest Codes in This Family
Official ICD-10-CM classifications closest to C32.0 in its code family, with their registry titles.